Blood Crystal is projected to decline to $0.0002325 by 2027, a -6% move from its current price of $0.000246. BC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.0002159 | $0.0002461 | $0.0002805 | +0.02% |
| Jul 14 | $0.0002046 | $0.0002461 | $0.0002962 | +0.05% |
| Jul 15 | $0.0001963 | $0.0002462 | $0.0003088 | +0.07% |
| Jul 16 | $0.0001895 | $0.0002463 | $0.0003199 | +0.10% |
| Jul 17 | $0.0001838 | $0.0002463 | $0.00033 | +0.12% |
| Jul 18 | $0.0001788 | $0.0002464 | $0.0003395 | +0.14% |
| Jul 19 | $0.0001743 | $0.0002464 | $0.0003484 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0001743 | $0.0002464 | $0.0003484 | +0.17% |
| Week 2 | $0.0001513 | $0.0002468 | $0.0004028 | +0.33% |
| Week 3 | $0.0001357 | $0.0002473 | $0.0004504 | +0.50% |
| Week 4 | $0.0001239 | $0.0002477 | $0.000495 | +0.67% |
| Week 5 | $0.0001144 | $0.0002481 | $0.000538 | +0.84% |
| Week 6 | $0.0001064 | $0.0002485 | $0.0005802 | +1.00% |
| Week 7 | $0.00009959 | $0.0002489 | $0.0006221 | +1.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Blood Crystal, symbol BC, is described as the utility token used within Eternal Crypt - Wizardry BC, a blockchain game that uses the Wizardry IP, historically known as the origin of RPGs. Players explore a dungeon called Dadoel's Hole with up to 36 adventurers, aiming for the abyss by designing party compositions and strategically training adventurers to defeat difficult enemies.
To earn BC tokens, you basically need to own this adventurer NFT, form a party and play the game. Adventurers come in four races (humans, elves, dwarves and felpers) and eight professions (warrior, monk, wizard, thief, priest, samurai, monarch and ninja), with rarities ranging from Common to Genesis. Rarities above Rare can be taken out of the game or bought and sold as NFT in the marketplace, and adventure rewards (BC tokens) vary with depth into the dungeon.
There are endless possibilities for party composition and strategy as you progress through dungeons, with the game emphasizing both easy-to-play mechanics and the unique strategic depth of Wizardry. Blood Crystal sits within Gaming (GameFi), Polygon Ecosystem, and Ethereum Ecosystem as its category classifications.
Blood Crystal (BC) is currently priced at $0.000246 with a market capitalization of $207.65K, and it is ranked 4566 by market cap. The token’s all-time high is $0.0927 and its all-time low is $0.0001854, illustrating substantial historical volatility.
The 30-day price range spans from $0.00009957 to $0.0006079, with the current price near the defined support level of $0.000246 and below a resistance near $0.0004996. The forecast landscape shows a wide set of possible outcomes over the coming years, including notable bullish periods later in the cycle and a high long-term potential, though current sentiment remains mixed.
Forecasts project a broad path with 2026–2030 fluctuating around the low end, then more pronounced gains in certain years (e.g., 2028–2029 and 2032–2034), culminating in a substantial long-run upside by 2050 (avg $0.001197, max $0.002753, ROI 386.6). These figures reflect estimates and are not guarantees.
In sum, BC trades at a very low price with a substantial historical range and volatility, and the year-by-year outlook shows both periods of upside and near-term caution. The long-run average suggests higher prices by 2050, but the path includes uncertainty and varying risk across years.
A major floor 68.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 103.1% above — a clean break opens room to run.
A major ceiling 220.9% above — clearing it would confirm fresh momentum.
Key BC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0002988 | Sell | $0.0002872 | Sell |
| MA 10 | $0.0003108 | Sell | $0.0003067 | Sell |
| MA 20 | $0.0003336 | Sell | $0.0003337 | Sell |
| MA 50 | $0.0003958 | Sell | $0.000402 | Sell |
| MA 100 | $0.0004963 | Sell | $0.0006506 | Sell |
| MA 200 | $0.001057 | Sell | $0.001755 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.14 | Neutral |
| Stoch RSI (14) | 44.79 | Neutral |
| CCI (20) | -165.39 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -28.15 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.09 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 38.36 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.00 | Sell |
| ADX (14) | 28.10 | Sell |
| ATR (14) | 0.00 | Info |
The near-term technical picture is Bearish, with RSI(14) at 40 and a price action biased toward downside momentum. The token trades below the near-term price signal implied by the SMA50 at $0.000397 and well below the SMA200 at $0.001068, underscoring a cautious regime.
Support sits at $0.000246, with resistance at $0.0004996. The 30-day range stretches from a low of $0.00009957 to a high of $0.0006079, indicating sizable intraperiod volatility. The current price is at the support level, suggesting limited downside until a break of that level occurs.
Annualized volatility runs high at 300%, underscoring the risk and potential for rapid swings in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.000246 | $0.000246 | $0.0003089 | 0% | Neutral | |
| $0.0001667 | $0.0002325 | $0.0003511 | -6% | Neutral | |
| $0.0003069 | $0.0004565 | $0.0007357 | +86% | Bullish | |
| $0.0002849 | $0.0004478 | $0.0007587 | +82% | Bullish | |
| $0.0001558 | $0.0002576 | $0.0004549 | +5% | Neutral | |
| $0.0001448 | $0.000251 | $0.0004592 | +2% | Neutral | |
| $0.0002809 | $0.0005095 | $0.000962 | +107% | Bullish | |
| $0.0002936 | $0.0005563 | $0.00108 | +126% | Bullish | |
| $0.0002018 | $0.000399 | $0.000795 | +62% | Bullish | |
| $0.0001385 | $0.0002856 | $0.0005826 | +16% | Neutral | |
| $0.0001319 | $0.0002931 | $0.0006587 | +19% | Neutral | |
| $0.0005387 | $0.001197 | $0.002753 | +387% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.000246 | $0.000246 | $0.0002651 | +0.00% |
| August 2026 | $0.000199 | $0.0002431 | $0.0003106 | -1.17% |
| September 2026 | $0.000203 | $0.0002514 | $0.0003276 | +3.40% |
| October 2026 | $0.0001552 | $0.0001947 | $0.000258 | -22.57% |
| November 2026 | $0.000143 | $0.0001811 | $0.0002436 | -6.94% |
| December 2026 | $0.0001771 | $0.0002267 | $0.0003089 | +25.15% |
Click any year to see its month-by-month BC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Blood Crystal's 2026 outlook centres on $0.000246, within a $0.000246 to $0.0003089 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BC could reach as high as $0.0003511, with a base case around $0.0002325 and support toward $0.0001667 — roughly -6% from $0.000246. A consolidation phase looks the most probable path here.
Expect BC to range from $0.0003069 to $0.0007357 through 2028. The $0.0004565 average target implies a +86% move from current prices. That is up +96% on the projected 2027 average. Momentum favours further upside here.
The BC price prediction for 2029 points to an average of $0.0004478 (low $0.0002849, high $0.0007587) — a potential gain of +82% on today's $0.000246. Buyers look set to stay in control over this stretch.
In 2030, BC is projected to trade between $0.0001558 and $0.0004549, averaging $0.0002576 — a potential gain of +5% from today's $0.000246. That is -42% versus the projected 2029 average. Price action looks broadly range-bound.
Blood Crystal's 2031 outlook centres on $0.000251, within a $0.0001448 to $0.0004592 range. That is -3% versus the projected 2030 average. That marks a +2% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, BC could reach as high as $0.000962, with a base case around $0.0005095 and support toward $0.0002809 — roughly +107% from $0.000246. Momentum favours further upside here.
Expect BC to range from $0.0002936 to $0.00108 through 2033. The $0.0005563 average target implies a +126% move from current prices. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BC price prediction for 2034 points to an average of $0.000399 (low $0.0002018, high $0.000795) — a potential gain of +62% on today's $0.000246. Momentum favours further upside here.
In 2035, BC is projected to trade between $0.0001385 and $0.0005826, averaging $0.0002856 — a potential gain of +16% from today's $0.000246. That is -28% versus the projected 2034 average. A consolidation phase looks the most probable path here.
Blood Crystal's 2040 outlook centres on $0.0002931, within a $0.0001319 to $0.0006587 range. That is up +3% on the projected 2035 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2050, BC could reach as high as $0.002753, with a base case around $0.001197 and support toward $0.0005387 — roughly +387% from $0.000246. Buyers look set to stay in control over this stretch.
Investing $1,000 in BC today (≈ 4,064,710.186164 BC) could be worth
$4,865.62
+$3,865.62 (+387%) by 2050 · US Dollar
Based on the average projected BC price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BCwould be worth at today's price.
$1,000 invested in BC on Jul 1, 2025 (≈ 214,618.34123 BC) would be worth
$52.8
-$947.2 (-94.7%) today · 0.05× · US Dollar
Based on a BC entry price of $0.004659 vs. today's $0.000246.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000328 | $749.97 | -25.0% |
| 1 month ago | $0.000452 | $544.85 | -45.5% |
| 3 months ago | $0.00063 | $390.8 | -60.9% |
| 6 months ago | $0.001979 | $124.34 | -87.6% |
| 1 year ago | $0.004659 | $52.8 | -94.7% |
| All time (1.1y) ago | $0.008797 | $27.97 | -97.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BC forecast.
Our base-case forecast reaches $0.00049 around 2032.
Implied market cap at $0.00049: $413.58K
The multi-year forecast shows a wide distribution of possible outcomes, with neutral to bullish tones emerging in different years. In 2026 the average price is projected at $0.000246 with ROI 0% and a Neutral sentiment. By 2027 the average is $0.0002325 with ROI -5.5% and Neutral sentiment, highlighting downside risk in that period.
The forecast turns more favorable in 2028 (avg $0.0004565, ROI 85.5%, Bullish) and 2029 (avg $0.0004478, ROI 82%, Bullish), pointing to meaningful upside as the cycle progresses. In 2030 the average is $0.0002576 with ROI 4.7% and Neutral sentiment, followed by gradual improvement into 2032–2033 (avg $0.0005095 and $0.0005563 with ROI 107.1% and 126.1%, Bullish), indicating a shifting risk/reward profile.
The long-run picture shows continued upside potential, with 2040 (avg $0.0002931, ROI 19.1%, Neutral) and 2050 (avg $0.001197, max $0.002753, ROI 386.6%, Bullish) highlighting substantial upside under certain scenarios. These are estimates, not guarantees, and the path includes notable volatility and year-to-year variation.
Overall, the long-term outlook exhibits significant upside potential alongside meaningful risk, with several bullish years and a pronounced jump by 2050. Investors should understand that forecasts are uncertain and subject to change as market conditions evolve.
Tap a question to reveal the answer.
Avg $0.0002576, min $0.0001558, max $0.0004549; ROI 4.7%; sentiment Neutral.
The forecast shows a wide range of outcomes across years, with some years projecting high ROI (e.g., 2032 107.1%; 2033 126.1%; 2050 386.6%), and others with lower or negative ROI. These figures are estimates and not guarantees.
Yes. The forecast max for 2033 is $0.00108, and the 2050 max is $0.002753, indicating potential to cross $0.001 in certain years.
Current price $0.000246; market cap $207.65K; rank 4566.
Low $0.00009957, high $0.0006079.
Blood Crystal Community Discussion
0Share your Blood Crystal price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.